Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Data safety monitoring board clears phase III Thymitaq trial to continue

May 23, 2003

PI3-kinase modulators with antiproliferative activity reported by Iconix

May 23, 2003

Millennium ships Velcade within a week of FDA approval

May 22, 2003

Kirin identifies new antitumor FGFR inhibitors

May 22, 2003

Sankyo describes new compounds with PPARgamma-agonist and antitumor activity

May 22, 2003

Water-soluble etoposide prodrugs prepared and tested by French research team

May 22, 2003

ExonHit Therapeutics claims novel antitumor compounds in recent patent

May 22, 2003

Bexarotene reported effective in parapsoriasis

May 21, 2003

Isis and Ercole collaborate on antisense drugs that regulate alternative RNA splicing

May 21, 2003

Lilly researchers describe new antitumor agents with utility in colorectal cancer

May 21, 2003

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...